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Insulin resistance is the best predictor for the development of type 2 diabetes. Recent studies
have shown that young, lean, insulin-resistant (IR) offspring of parents with type 2 diabetes
have reduced basal rates of muscle mitochondrial phosphorylation activity associated with
increased intramyocellular lipid (IMCL) content, which in turn blocks insulin signaling and
insulin action in muscle. In order to further characterize mitochondrial activity in these
individuals, we examined insulin-stimulated rates of adenosine triphosphate (ATP) synthesis
and phosphate transport in skeletal muscle in a similar cohort of participants.
Methods and Findings
Rates of insulin-stimulated muscle mitochondrial ATP synthase flux and insulin-stimulated
increases in concentrations of intramyocellular inorganic phosphate (Pi) were assessed by
31P
magnetic resonance spectroscopy (MRS) in healthy, lean, IR offspring of parents with type 2
diabetes and healthy, lean control participants with normal insulin sensitivity. IMCL content in
the soleus muscle of all participants was assessed by
1H MRS. During a hyperinsulinemic-
euglycemic clamp, rates of insulin-stimulated glucose uptake were decreased by approximately
50% in the IR offspring compared to the control participants (p ¼ 0.007 versus controls) and
were associated with an approximately 2-fold increase in IMCL content (p , 0.006 versus
controls). In the control participants rates of ATP synthesis increased by approximately 90%
during the hyperinsulinemic-euglycemic clamp. In contrast, insulin-stimulated rates of muscle
mitochondrial ATP synthesis increased by only 5% in the IR offspring (p¼0.001 versus controls)
and was associated with a severe reduction of insulin-stimulated increases in the intra-
myocellular Pi concentrations (IR offspring: 4.7% 6 1.9% versus controls: 19.3% 6 5.7%; p ¼
0.03). Insulin-induced increases in intramyocellular Pi concentrations correlated well with
insulin-stimulated increases in rates of ATP synthesis (r ¼ 0.67; p ¼ 0.008).
Conclusions
These data demonstrate that insulin-stimulated rates of mitochondrial ATP synthesis are
reduced in IR offspring of parents with type 2 diabetes. Furthermore, these IR offspring also
have impaired insulin-stimulated phosphate transport in muscle, which may contribute to their
defects in insulin-stimulated rates of mitochondrial ATP synthesis.
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Type 2 diabetes affects about 171 million people world-
wide, and the number of people likely to be affected by
diabetes is expected to double by 2030 [1,2]. Diabetes
develops when resistance to insulin action combines with
impaired insulin secretion, resulting in hyperglycemia. Cross-
sectional studies have demonstrated the presence of insulin
resistance in virtually all patients with type 2 diabetes, and
prospective studies have demonstrated the presence of
insulin resistance one to two decades prior to the onset of
the disease [3,4]. In addition, insulin resistance in the insulin-
resistant (IR) offspring of parents with type 2 diabetes has
been shown to be the best predictor for the later develop-
ment of the disease [5]. Although the mechanism for their
insulin resistance is unknown, previous studies have demon-
strated a strong relationship between dysregulated intra-
cellular fatty acid metabolism and insulin resistance in
skeletal muscle [6–8]. Increases in certain intramyocellular
lipid (IMCL) metabolites such as acyl CoAs and diacylglycerol
have in turn been shown to block insulin signaling by
activating a serine kinase cascade [9–12], resulting in reduced
insulin-stimulated muscle glucose transport activity [10] and
decreased muscle glycogen synthesis [13,14]. Recent com-
bined
1H and
31P magnetic resonance spectroscopy (MRS)
studies have demonstrated an approximately 2-fold increase
in the IMCL content in a group of healthy, young, lean, IR
offspring of parents with type 2 diabetes associated with a
30% reduction in basal rates of muscle mitochondrial
adenosine triphosphate (ATP) production. These data suggest
that defects in mitochondrial activity, due to reduction in
mitochondrial content and/or function, may be an important
contributing factor to their increased IMCL content and
insulin resistance [15]. Consistent with these functional MRS
data two recent gene microarray studies have found a
coordinated reduction in peroxisome proliferator-activated
receptor c coactivator 1 responsive genes that are involved in
mitochondrial oxidative phosphorylation activity in muscle
biopsy samples obtained from obese participants with type 2
diabetes [16,17] and their overweight ﬁrst-degree relatives
[17].
In order to further characterize mitochondrial function in
these individuals we measured insulin-stimulated rates of
muscle mitochondrial ATP synthesis and changes in intra-
myocellular inorganic phosphate (Pi) concentrations using
31P MRS in a similar group of young, lean, IR offspring of
parents with type 2 diabetes and body mass index (BMI)–age–
activity-matched control participants. These individuals are
ideal for examining the earliest defects responsible for the
pathogenesis of insulin resistance since, in contrast to
patients with diabetes, they are young, lean, healthy, and
they have none of the other confounding factors that are
likely to be present in patients with type 2 diabetes.
Methods
Participants
All volunteers were prescreened to be healthy, taking no
medications, lean, nonsmoking, of normal birth weight
(.2.25 kg), and sedentary, as deﬁned by an activity index
questionnaire [18]. IR offspring (four male and three female)
had at least one parent or grandparent with type 2 diabetes
and at least one other family member with type 2 diabetes. All
qualifying participants underwent a complete medical history
and physical examination along with blood tests to verify
normal: blood and platelet count, electrolytes, aspartate
amino transferase, alanine amino transferase, blood urea
nitrogen, creatinine, cholesterol, and triglyceride. IR off-
spring were deﬁned by an insulin (240 pmol/m
2/min)–
stimulated glucose infusion rate ,4.85 mg/kg/min, whereas
the control participants were deﬁned by a rate of insulin-
stimulated glucose uptake .6 mg/kg/min.
Written consent was obtained from each participant after
the purpose, nature, and potential complications of the
studies were explained. The protocol was approved by the
Yale University Human Investigation Committee.
Diet and Study Preparation
Participants were instructed to abstain from any exercise
and to eat a regular, weight maintenance diet containing at
least 150 g of carbohydrate per day for the 3 d prior to the
studies. To minimize changes in ovarian hormonal effects on
glucose metabolism, the female participants were studied
during the follicular phase (days 0–12) of the menstrual cycle
[19].
Hyperinsulinemic-Euglycemic Clamp
Participants were admitted to the Yale University–New
Haven Hospital General Clinical Research Center the evening
before the studies and remained fasting from 10 p.m. until
the end of the study the next day. At 6 a.m. antecubital IV
catheters were inserted, and at 7 a.m. the participants were
placed inside the 2.1T magnetic resonance spectrometer
(Biospec Spectrometer, Bruker Instruments, Billerica, Massa-
chusetts, United States) with the right calf positioned over the
31P receiver coil. After baseline
31P MRS measurements of
ATP synthesis ﬂux and muscle intramyocellular Pi concen-
trations (described below), a primed-continuous insulin
infusion was begun (240 pmol/m
2/min) to raise plasma insulin
concentrations to approximately 480 pmol/l and to maintain
them at this level throughout the remaining 150 min of the
clamp. Blood was collected every 5 min for determination of
plasma glucose concentrations, and a variable intravenous
infusion of dextrose (200 g/l) was administered to raise plasma
glucose concentrations to 100 mg/dl and maintained at this
concentration until the end of the clamp.
Metabolites and Hormones
Plasma glucose concentrations were measured using a
Glucose Analyzer II (Beckman Instruments, Fullerton, Cal-
ifornia, United States). Plasma concentrations of insulin were
measured using double-antibody radioimmunoassay kits
(Linco, St. Louis, Missouri, United States). Plasma fatty acid
concentrations were determined using a microﬂuorimetric
method [20]. Urine nitrogen content was measured at the
Mayo Medical Laboratories (Rochester, Minnesota, United
States).
31PM R S
Rates of mitochondrial phosphorylation activity were
assessed by
31P MRS saturation transfer performed at 36.31
MHz using a ﬂat, concentric probe made of a 9-cm-diameter
inner coil (for
31P) and a 13-cm outer coil tuned to proton
frequency for scout imaging and shimming as previously
described [15,21]. Unidirectional rates of ATP synthesis were
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saturation transfer method applied to the exchange between
intracellular phosphate and ATP [21]. The steady-state
intramyocellular Pi magnetization was measured in the
presence of a selective irradiation of the c resonance of
ATP and compared to the equilibrium intracellular phos-
phate magnetization in a control spectrum (without irradi-
ation of c ATP) [21]. Total acquisition time for
31P spectra
was about 120 min (from t ¼ 30 to 150 min of the clamp).
1H MRS of IMCL Content
On a separate day, after a 12-h fast, all participants were
transported by wheelchair to the Yale Magnetic Resonance
Center and localized
1H MRS of the soleus muscle to assess
IMCL content were acquired on a 2.1T Biospec as previously
described [22].
Indirect Calorimetry
Rates of whole-body energy expenditure and glucose and
fat oxidation were assessed by indirect calorimetry (Deltra-
track Metabolic Monitor, Sensormedics, Anaheim, California,
United States) during the last 20 min of the baseline period
and during the last 20 min of the clamp [23].
Calculations
Hyperinsulinemic-euglycemic clamp. The rates of glucose
infusion were calculated in 15-min blocks from 60–150 min
during the insulin clamp. The data were corrected for urinary
glucose loss and glucose space and were expressed as
milligrams glucose metabolized per kilogram body weight
per minute.
Indirect calorimetry. Basal and insulin-stimulated glucose
and lipid oxidation rates were measured by the ventilated
hood technique, using a Deltatrack Metabolic Monitor (as
previously described [24]). The nonprotein respiratory
quotients for 100% oxidation of fat and for oxidation of
carbohydrates were 0.707 and 1.00, respectively [24]. Non-
oxidative glucose metabolism was calculated by subtracting
the amount of glucose oxidized from the total amount of
glucose infused.
Statistical analyses. Statistical analyses were performed
using the unpaired t-test to detect statistical differences
between control and IR offspring, and the paired student t-
tests were performed to test for interparticipant differences.
A p-value (two-sided) of ,0.05 was considered signiﬁcant. All
data are expressed as mean 6 SEM.
Results
Participant Characteristics
The control participants and IR offspring were group
matched for age, weight, height, BMI, and activity (Table 1).
All participants were lean, nonsmoking, and had a sedentary
lifestyle without regular participation in sports activities.
Hyperinsulinemic-Euglycemic Clamp
Rates of insulin-stimulated glucose metabolism were
approximately 50% lower in the IR offspring compared to
the control participants (control: 8.56 6 0.88 mg/[kg/min] and
IR offspring: 4.54 6 0.11 mg/[kg/min]; p , 0.001) (Figure 1A).
This reduction in insulin-stimulated rate of whole-body
glucose metabolism was associated with an approximately
90% increase in the IMCL content in the IR offspring (1.68%
6 0.21% versus controls: 0.86 6 0.09%, p ¼ 0.006) and could
mostly be attributed to an approximately 60% reduction (p ,
0.001) in nonoxidative glucose disposal (Table 2).
31PM R S
During insulin stimulation, rates of mitochondrial phos-
phorylation activity increased by approximately 90% in the
control participants (Figure 1B). In contrast, insulin-stimu-
lated ATP synthase ﬂux was severely blunted in the IR
offspring (DATP ﬂux: 5% 6 2%; p ¼ 0.001) (Figure 1B).
During insulin stimulation concentrations of intramyocellu-
lar Pi increased by 19.3% 6 5.7% in the control participants,
whereas insulin-stimulated increases in intramyocellular Pi
concentrations were also severely blunted in the IR offspring
(DPi: 4.7% 6 1.9%; p ¼ 0.03 versus controls) (Figure 1C).
There was a strong correlation between insulin-induced
increases in intramyocellular Pi concentrations, and the
insulin-stimulated increases in rates of ATP synthesis (r ¼
0.67; p ¼ 0.008). In order to determine whether or not these
changes in intramyocellular Pi might be attributable to
insulin-induced alterations in phosphocreatinine (PCr) me-
tabolism, we also assessed the PCr/ATP ratio before and
during the clamp in both groups of participants. We found no
changes in the PCr/ATP ratio during the hyperinsulinemic-
euglycemic clamp compared to the basal period in either the
control participants (basal: 4.36 6 0.06 versus clamp: 4.30 6
0.31) or IR offspring (basal: 3.82 6 0.17 versus clamp: 3.91 6
0.33).
Discussion
Recent studies have demonstrated an approximately 30%
reduction in basal rates of mitochondrial ATP synthesis in
healthy, young, lean, IR offspring of parents with type 2
diabetes, which were associated with an approximately 2-fold
increase in IMCL content [15]. We postulated that reductions
in mitochondrial activity might predispose these individuals
to increased IMCL accumulation, which in turn would lead to
defects in insulin signaling and insulin action in skeletal
muscle. In order to further characterize the regulation of
mitochondrial activity in these individuals, we assessed
insulin-stimulated rates of ATP synthesis in a similar group
of young, lean, IR offspring as well as in a group of age–BMI–
activity-matched control group participants using
31P MRS.
We found that insulin was a potent stimulator of muscle ATP
synthesis in that it increased this ﬂux by 90% over basal rates
Table 1. Characteristics of the Two Groups of Participants
Characteristic Control (n ¼ 7) IR Offspring (n ¼ 7) p-Value
Age (y) 29 6 22 8 6 2 n.s.
Weight (kg) 66 6 46 8 6 5 n.s.
Height (m) 1.76 6 0.04 1.75 6 0.03 n.s.
BMI (kg/m
2) 21.3 6 0.8 22.2 6 0.9 n.s.
Activity index 2.7 6 0.2 2.4 6 0.1 n.s.
IMCL (%) 0.86 6 0.09 1.68 6 0.21 0.006
M-value (mg/kg/min) 8.56 6 0.88 4.54 6 0.11 ,0.001
Insulin sensitivity index 7.3 6 0.6 5.0 6 0.8 0.05
DOI: 10.1371/journal.pmed.0020233.t001
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rates of ATP synthase ﬂux were severely blunted in the IR
offspring where a similar increase in plasma insulin concen-
trations increased this ﬂux by only 5% over basal rates. These
data demonstrate that the defects in basal rates of mitochon-
drial phosphorylation activity, previously found in the IR
offspring, are even more pronounced under insulin-stimu-
lated conditions and are consistent with a recent in vitro
study that found reduced insulin-stimulated rates of oxidative
phosphorylation activity in isolated mitochondria obtained
from muscle biopsy samples of participants with type 2
diabetes [25]. Taken together these data suggest that the
observed defect in insulin-stimulated rates of ATP synthesis is
a very early defect in the pathogenesis of insulin resistance
and type 2 diabetes.
Insulin also stimulates intramyocellular Pi transport into
skeletal muscle, which accounts for much of its hypophos-
phatemic effects in vivo. Previous in vitro studies by Polgreen
et al. [26] have demonstrated that insulin stimulates Na-
dependent intramyocellular Pi inﬂux in a mouse myoblast cell
line in a relatively rapid manner that is independent of
protein synthesis. These authors speculated that insulin
regulates intramyocellular Pi transport into skeletal muscle
by recruitment of intramyocellular Pi transporters to the cell
surface in a fashion similar to insulin regulation of glucose
transport activity in skeletal muscle. Using
31P MRS to assess
intramyocellular Pi content before and during the hyper-
insulinemic-euglycemic clamp, we found a marked reduction
of insulin-stimulated intramyocellular Pi transport into
skeletal muscle of the IR offspring. The parallel reductions
in insulin-stimulated rates of muscle glucose metabolism,
which can mostly be attributed to reduced insulin-stimulated
glucose transport activity [27], and reduced insulin-stimu-
lated phosphate transport activity suggests that a common
insulin-signaling defect may be responsible for both of these
abnormalities [28]. We also observed a strong correlation
between insulin-stimulated increases in intramyocellular
phosphate concentrations and insulin-stimulated increases
in rates of ATP synthesis in control participants and IR
offspring. Inorganic phosphate is the substrate for the
phosphorylation of adenosine diphosphate to ATP during
oxidative phosphorylation, and it is also a putative cytosolic
signaling molecule in the regulation of this process [29,30].
Recent in vitro studies in isolated heart mitochondria have
demonstrated that inorganic phosphate regulates oxidative
phosphorylation by inﬂuencing both the proton motive force
and the rate of ATP production [31]. Taken together these
data suggest that insulin regulation of phosphate transport
may be an important mechanism by which insulin regulates
ATP synthesis in human skeletal muscle. If this is true, then it
is possible that the observed reductions in insulin-stimulated
rates of muscle ATP synthesis, which were observed in the IR
offspring, may be secondary to the increased IMCL content
that results in impaired insulin signaling and decreased
insulin-stimulated phosphate transport [9–12]. While it is also
possible that reduced insulin-stimulated muscle capillary
recruitment [32–34] might be responsible for the observed
reductions in insulin stimulation of ATP synthesis and
intramyocellular Pi transport in the IR offspring, recent
studies in humans [27,35–37] have shown that the majority of
insulin resistance can be accounted for by a decrement in
insulin’s stimulatory effects on cellular glucose uptake and
that stimulation of blood ﬂow and capillary recruitment plays
only a minor role in mediating insulin effects on glucose
metabolism in human skeletal muscle. Therefore it appears
unlikely that reductions in insulin-stimulated muscle capil-
lary recruitment have a major role in explaining the observed
Figure 1. Effect of Insulin Stimulation
(A) Rates of whole-body glucose metabolism, (B) rates of muscle
mitochondrial ATP synthesis, and (C) intramyocellular Pi concentrations.
DOI: 10.1371/journal.pmed.0020233.g001
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myocellular Pi transport in the IR offspring.
In summary, these data provide further evidence of
mitochondrial dysfunction in skeletal muscle of IR offspring
of parents with type 2 diabetes. These individuals also
manifest severe defects in insulin-stimulated phosphate
transport in skeletal muscle, which may contribute to their
observed defects in insulin-stimulated rates of mitochondrial
ATP synthesis. Given the potentially important role that
intracellular phosphate might have on regulating mitochon-
drial ATP production, we propose that regulation of intra-
myocellular Pi transport into the muscle cell by insulin may
be an important mechanism by which insulin regulates
mitochondrial ATP synthesis in skeletal muscle.
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Patient Summary
Background Type 2 diabetes is one of the fastest growing chronic
diseases. We know quite a bit about the risk factors that predispose
people to diabetes (such as being overweight), but we do not
understand well how the disease starts (usually in adults but increasingly
in teenagers and even children).
Why Was This Study Done? Children whose parents are diabetic have a
higher risk of developing type 2 diabetes themselves. Some of them
have the first signs of the disease (a condition called insulin resistance,
which is a strong predictor for subsequent development of diabetes)
while they are still young and lean. The group of Gerald Shulman (who is
the senior author of this study) has studied such individuals to
understand the causes and effects of their insulin resistance. Having
previously found some abnormalities in the mitochondria (the parts of
cells involved in generating energy), they studied mitochondrial function
in more detail here.
What Did the Researchers Do and Find? They compared seven young
lean insulin-resistant adults with a family history of diabetes with seven
lean young adults without diabetic family members and with normal
insulin sensitivity. Specifically, they looked at energy generated in the
muscles in response to insulin stimulation. They found that while insulin
increases energy production in the muscles of the control individuals by
approximately 90%, it had very little effect in the insulin-resistant
individuals. They also studied the amount of inorganic phosphate (an
essential trace element) in muscle cells of both groups, and how it was
affected by insulin. They found that in control individuals, insulin results
in an increase of phosphate transport into the muscle cells and that this
is also much reduced in insulin-resistant individuals.
What Does This Mean? Intracellular phosphate is a key regulator of
energy generation, and this study provides more support for the notion
that insulin resistance compromises proper functioning of energy
generation in the mitochondria of muscle cells. This and similar studies
should eventually result in a better understanding of the early events in
diabetes. The hope is that this will then allow the development of
therapies that might prevent the disease or treat its symptoms more
effectively.
Where Can I Find More Information Online? The following Web sites
contain information on diabetes and insulin resistance.
US National Diabetes Clearinghouse (English and Spanish):
http://diabetes.niddk.nih.gov/dm/pubs/insulinresistance/
http://diabetes.niddk.nih.gov/spanish/indexsp.asp





American Diabetes Association (English and Spanish):
http://www.diabetes.org/
http://www.diabetes.org/espanol/default.jsp
Information on Dr. Shulman’s research:
http://www.hhmi.org/research/investigators/shulman.html
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